Opus Genetics IRD SEC Filings

NASDAQ IRD
$4.66 +0.07 (+1.41%)
As of: Sep 4, 2026 · 3:15 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Opus Genetics, Inc. (IRD) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index